Exploiting Innate γδ T Lymphocytes for Tumor Immunotherapy

Publisher： Bentham Science Publishers

E-ISSN： 2210-3104|1|1|81-88

ISSN： 2210-3090

Source： Recent Patents on Biomarkers, Vol.1, Iss.1, 2011-01, pp. : 81-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human γδ T lymphocytes

By Rothenfusser S.   Buchwald A.   Kock S.   Ferrone S.   Fisch P.  

Cellular Immunology, Vol. 215, Iss. 1, 2002-01 ,pp. : 32-44

Academic Press

Access to resources Recommend Favorite

TCRalphabeta + Anti-Tumor Cytolytic T Lymphocytes Express NKR-P1 While the Anti-Tumor Activity of TCRgammadelta + T Lymphocytes Is Not Correlated to NKR-P1 Expression

By Yrlid U.   Petersson E.   Dohlsten M.   Hedlund G.  

Cellular Immunology, Vol. 173, Iss. 2, 1996-11 ,pp. : 287-294

Academic Press

Access to resources Recommend Favorite

Induction of auto-logous human cytotoxic T lymphocytes (CTL) from peripheral blood against tumor cells

By Ohno T.  

Cytotechnology, Vol. 23, Iss. 1-3, 1997-01 ,pp. : 197-203

Springer Publishing Company

Access to resources Recommend Favorite

HLA Class I-Restricted and Tumor-Specific Cytotoxic T Lymphocytes from Metastatic Lymph Nodes of Esophageal Cancers

By Toh U.   Yamana H.   Nakao M.   Imai Y.   Seki N.   Takasu H.   Kaneshige T.   Fujita H.   Shirouzu K.   Itoh K.  

Cellular Immunology, Vol. 177, Iss. 2, 1997-05 ,pp. : 137-143

Academic Press

Access to resources Recommend Favorite

Telomerase as a tumor-associated antigen for cancer immunotherapy

By Patel Kunal P.   Vonderheide Robert H.  

Cytotechnology, Vol. 45, Iss. 1-2, 2004-06 ,pp. : 91-99

Springer Publishing Company

Access to resources Recommend Favorite